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ZINC plays an important role in wound
healing (Pories et al., 1967) and may also
be concerned with the body's attempt to
localize malignant disease. The latter
possibility is suggested by the finding of
elevated zinc concentrations in the un-
involved portions of liver invaded by
metastases (Olson, Heggen and Edwards,
1958; Wright and Dormandy, 1973) or in
liver tissue when a neoplasm is present
elsewhere (Olson et al., 1958; Wright and
Dormandy, 1973), and also by the in-
hibitory effect of oral zinc on the develop-
ment of certain tumours in experimental
animals (Poswilo and Cohen, 1971). High
zinc levels might then be expected in the
unaffected liver tissue in patients with
primary hepatic cancer (PLC). Investi-
gation ofthis possibility is complicated by
the fact that PLC frequently develops in
cirrhotic livers (Sagebiel, McFarland and
Taft, 1963; Lin, 1970), which may have
subnormal zinc concentrations (Vallee
et al., 1957; Butt and Higginson, 1957;
Boyett and Sullivan, 1970). A compari-
son was therefore made between the zinc
levels in both cirrhotic and non-cirrhotic
livers associated with PLC and those in
non-cirrhotic livers without PLC.
MATERIALS AND METHODS
Tissue for zinc analysis was obtained at
necropsy from 37 patients with PLC and 33
patients dying from a variety of non-
cancerous illnesses but whose livers were
histologically normal. All the patients were
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negro males; the ages at the time of death of
the subjects in the 2 groups were comparable.
In the cancer cases, duplicate specimens
were taken both from obviously cancerous
tissue and from liver tissue (cirrhotic or
non-cirrhotic) well away from the tumour.
In 23 of these patients the liver was cirrhotic
while in 11 the tumour arose in an otherwise
normal liver. (In the remaining 3 the liver
was so extensively invaded by tumour that
it was not possible to obtain adequate
samples of tissue free from malignancy.)
The cirrhosis was of the macronodular
(postnecrotic) variety in each case. Dupli-
cate samples were taken from the normal
liver of the non-cancerous patients. The
specimens were wiped free of blood, weighed,
placed in glass bottles and stored at 0°C until
analysis.
At the time of analysis the tissue was
transferred into a tall 125 ml Pyrex beaker
and digested using a mixture of 5 ml nitric
acid and 2 ml perchloric acid. The beaker
was covered and gently heated on a hot plate
in a fume cupboard until only a few drops of
clear liquid remained. This was diluted
with distilled water to a volume of 10 ml in a
volumetric flask. Zinc assay was per-
formed on a Techtron AA4 or AA5 atomic
absorption spectrophotometer using stan-
dards of pure zinc metal dissolved in nitric
acid. A reagent blank was taken through
the digestion procedure, since even A.R.
grade reagents contain small amounts of
zinc. All glassware used was decontami-
nated with hot aqua regia, followed by
thorough washing with distilled water.
The instrument settings were as follows:
wavelength 214 nm, air pressure 15 psi,
acetylene flow setting Ca 4, slit width
300 ,um, lamp current 6 mA, burner AB-41.HEPATIC ZINC CONCENTRATIONS IN PRIMARY CANCER OF THE LIVER
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FIG. 1.-Individual zinc concentrations together with the means and standard deviations of the
tissues analysfd. The values for normal liver from non-cancerous patients are shown in the first
column, non-cirrhotic liver from PLC patients in the second, cirrhotic liver from PLC patients in the
thir(l and liver cancer tissue in the fourth.
RESULTS
The zinc concentration of the tissues
analysed are shown in Fig. 1. The
difference between zinc levels in normal
liver from non-cancerous patients and
non-cirrhotic liver from PLC patients is
clearly not significant, but the difference
between cirrhotic liver from PLC patients
and normal liver from non-cancerous
patients is significant (P < 0.001 on a
modified Student's t test). The differ-
ence between cirrhotic and non-cirrhotic
liver from PLC patients is also significant
(P < 0.005). The zinc concentration in
the liver cancer tissue was significantly
less than that in the non-cancerous tissues,
whether cirrhotic or non-cirrhotic in the
PLC patients or normal from the non-
cancerous patients (P < 0.001 in each
instance).
DISCUSSION
Liver zinc concentrations in patients
dying from non-cancerous medical ill-
nesses do not differ significantly from those
dying from acute trauma (McBean et al.,
1972). Our control group consisted ofthe
former type of patient but with the
added proviso that the liver was histo-
logically normal, and the mean zinc con-
centration was similar to that reported by
Koch et al. (1956) in normal livers.
Although haemosiderosis is common in
South African negro males (Charlton,
Bothwell and Seftel, 1973), and iron and
zinc metabolism is known to be inter-
related (Davies, 1972), the presence of
excess tissue iron does not appear to
affect hepatic zinc levels significantly
(Butt and Higginson, 1957). A wide
variation in the zinc concentration of
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apparently normal livers has also been a
feature of previous studies (Koch et al.,
1956; Olson et al., 1958).
The relationship, if any, between zinc
and malignant disease is uncertain. On
the one hand, excessive intake of zinc has
been incriminated in the aetiology of
various forms of cancer, e.g. stomach
cancer in England (Stocks and Davies,
1964) and Japan (Hirayama, 1962), and
oesophageal cancer in Africa (McGlashan,
1967), and Chahovitch (1955) has shown
that injection of zinc sulphate increases
experimental tumour growth. In addi-
tion, dietary zinc deficiency inhibits the
growth of experimental carcinosarcomata
(De Wys et al., 1970). On the other hand,
the development of other tumours in
experimental animals is inhibited by oral
zinc (Poswilo and Cohen, 1971). The
high zinc content in the unaffected
portions of liver containing metastatic
deposits and in liver tissue when a neo-
plasm is present elsewhere (Olson et al.,
1968; Wright and Dormandy, 1973) sug-
gests that zinc mayplay a role in the tissue
reaction to malignant disease. This func-
tion would be expected to apply equally
to tissues other than the liver, and to the
growth and spread of the primary lesion
as well as metastases. Our finding of
normal zinc levels in non-cirrhotic liver
tissue in patients with PLC therefore
argues against this hypothesis, at least in
as far as the South African negro is
concerned.
Subnormal hepatic zinc levels occur in
alcoholic cirrhosis (Vallee et al., 1957;
Boyett and Sullivan, 1970) and also in
South African negroes with cirrhosis
(Butt and Higginson, 1957). The latter
observation was confirmed in the present
study, in which the cirrhosis was of the
macronodular (postnecrotic) variety.
The statement by Addink and Frank
(1959) that high serum zinc levels occur
in association with tumours arising in
tissues rich in zinc, such as the liver,
would therefore not apply to PLC when
cirrhosis is present. PLC is commonly
associated with cirrhosis, the figure rang-
ing from 16 to 80% in different parts of
the world (MacDonald, 1957; Sagebiel,
McFarland and Taft, 1963; Ying et al.,
1963; Lin, 1970). Between 50 and 100%
of these tumours in the indigenous people
of southern Africa occur in cirrhotic livers
(Berman, 1951; Becker and Chatgidakis,
1961; Geddes and Falkson, 1970), and in
this series the figure was 66%. However,
in the absence of cirrhosis the hepatic
zinc concentration did not differ from
that ofthe " control " livers, and elevated
serum levels might therefore occur in these
patients. The tumour itself is probably
not the source of the serum zinc as the
levels are low. Similar values have been
reported in hepatic metastases (Olson
et al., 1958) which are not associated with
raised serum levels (Vikbladh, 1951;
Wolff, 1956; Davies, Musa and Dormandy,
1968).
We are indebted to the staff of the
National Institute for Research into
Occupational Diseases for their co-opera-
tion, and to the photographic unit of the
Department of Medicine for Fig. 1.
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